Eosinophilic Airway Inflammation: Relationship to Remodeling and Modulation by Mepolizumab.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2017
At a glance
- Drugs Mepolizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 11 Dec 2012 Planned end date changed from 1 Aug 2013 to 1 Jan 2013 as reported by ClinicalTrials.gov.
- 11 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Dec 2008 New trial record.